Business By Rebecca Robbins With big-name backing, a startup launches to match cancer patients with clinical trials
Health By Rebecca Robbins How a society gala was used to sell young-blood transfusions to baby boomers desperate to cheat death
Special Report By Caroline Chen and Riley Wong — ProPublica Denied ‘life-extending opportunities’: Black patients are being left out of clinical trials amid wave of new cancer therapies
Health By Ike Swetlitz African-Americans are disproportionately enrolled in studies that don’t require informed consent
First Opinion By Jonathan Kimmelman and Alex John London Cancer centers sell out science when they advertise clinical trials as treatment
Health By Rebecca Robbins Can you predict future brain damage? Hundreds of pro fighters are helping researchers find out
First Opinion By Jude Komuves Building a diverse and inclusive health care company takes work but is worth the effort
First Opinion By Jane L. Delgado and Edward Abrahams Diversity in clinical trials defines good science and better medicine
Opinions Plus By Leslie Loveless To recruit top life sciences executives, companies need solid strategies in 2019
First Opinion By Jennifer Dent Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that
Biotech By Rebecca Robbins Stock, sky-high salaries and a $10,000 watch: Startups desperately compete for top experts in gene and cell therapy
First Opinion By Mason Marks and Tiffany Li DNA donors must demand stronger protection for genetic privacy
In the Lab By Elizabeth Cooney Researchers mine emergency contacts to discover genetic clues to disease
Biotech By Jonathan Saltzman — Boston Globe The growth of Mass. biotechs is outpacing the number of qualified workers
First Opinion By Melissa Burstein More female leaders will help drive innovation in the medtech and biotech industries
First Opinion By Andy Coravos and Sofia Warner Blockchains and health care: promising and moving quickly, though no silver bullet